Healthy Skepticism Library item: 6611

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Follow-up: Sigma’s promotion of Asig (quinapril)
MaLAM Australian News 1995 Dec; 3:(12):2

Abstract:

Sigma has responded to MaLAM’s earlier letter about the promotion of its ACE inhibitor Asig (quinapril). MaLAM analyzes the responses and comments on them. MaLAM does not find the responses adequately answer all of its earlier questions.

Keywords:
*analysis/Australia/developed countries/Sigma/Asig/quinapril/ ACE inhibitor/ industry perspective/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ company responses/ATTITUDES REGARDING PROMOTION: INDUSTRY/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES